{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:42:15Z","timestamp":1780098135563,"version":"3.54.0"},"reference-count":50,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T00:00:00Z","timestamp":1123804800000},"content-version":"vor","delay-in-days":1898,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To determine whether nifedipine or prazosin is the more appropriate second\u2010line antihypertensive agent in pregnancy.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> Randomised controlled trial.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> Tygerberg Hospital, a tertiary referral centre.<\/jats:p><jats:p><jats:bold>Population\n\t\t\t\t\t<\/jats:bold> Women with early, severe pre\u2010eclampsia or hypertension in pregnancy, whose blood pressure could not be adequately controlled by methyldopa 2 g\/day, but were otherwise stable.<\/jats:p><jats:p><jats:bold>Methods\n\t\t\t\t\t<\/jats:bold> Nifedipine or prazosin were given and increased as necessary in a stepwise fashion. Once the maximum dose was reached, the other drug was added in a crossover pattern. Failure to control blood pressure, or the onset of maternal\/fetal complications were indications for delivery. Patients reaching a minimum gestation of 34 weeks without complications were delivered electively.<\/jats:p><jats:p><jats:bold>Main outcome measures\n\t\t\t\t\t<\/jats:bold> Antenatal days gained; major maternal complications and perinatal survival.<\/jats:p><jats:p><jats:bold>Results\n\t\t\t\t\t<\/jats:bold> Days gained on the second antihypertensive agent did not differ significantly (<jats:styled-content><jats:italic>P<\/jats:italic>= 0.9<\/jats:styled-content>), while more days were gained using nifedipine as the crossover \u2018third agent\u2019 (<jats:styled-content><jats:italic>P<\/jats:italic>= 0.01<\/jats:styled-content>). In the nifedipine group better renal function was recorded, but more cases with isolated low platelet counts occurred. More cases of pulmonary oedema as well as more nonviable mid\u2010trimester and third trimester intrauterine deaths occurred in the prazosin group.<\/jats:p><jats:p><jats:bold>Conclusion\n\t\t\t\t\t<\/jats:bold> Nifedipine and prazosin as second agents allowed comparable amounts of time to be gained, although this changed when used as crossover third\u2010line agents. The efficacy and safety of nifedipine in this study are consistent with the results of other studies. A greater number of intrauterine deaths occurred in the prazosin group.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2000.tb13337.x","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T10:39:27Z","timestamp":1123843167000},"page":"759-765","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Nifedipine or prazosin as a second agent to control early severe hypertension in pregnancy: a randomised controlled trial"],"prefix":"10.1111","volume":"107","author":[{"given":"D. R.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"Odendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. W.","family":"Steyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91176-D"},{"key":"e_1_2_5_3_2","volume-title":"Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991\u20131993","year":"1996"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1992.tb13818.x"},{"key":"e_1_2_5_5_2","first-page":"412","article-title":"Maternal mortality in the Cape Province, 1990\u20131992","volume":"86","author":"Theron GB","year":"1996","journal-title":"S Afr Med J"},{"key":"e_1_2_5_6_2","first-page":"808","article-title":"Total perinatally related wastage at Tygerberg Hospital: a comparison between 1986 and 1993","volume":"87","author":"Prins CA","year":"1997","journal-title":"S Afr Med J"},{"key":"e_1_2_5_7_2","unstructured":"OdendaalES SteynDW OdendaalHJ.Obstetric causes for delivery of very low birth weight babies at Tygerberg Hospital.Seventeenth Conference on Priorities in Perinatal Care in Southern Africa March 1998."},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199511233332106"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)81120-6"},{"key":"e_1_2_5_10_2","first-page":"1070","article-title":"Aggressive or expectant management for patients with severe preeclampsia between 28\u201334 weeks gestation: a randomised controlled trial","volume":"76","author":"Odendaal HJ","year":"1990","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(94)90104-X"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1989.tb03193.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641958909072245"},{"key":"e_1_2_5_14_2","first-page":"1071","article-title":"Improved perinatal mortality rates in 1001 patients with severe preeclampsia","volume":"85","author":"Odendaal HJ","year":"1995","journal-title":"S Afr Med J"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(97)00234-8"},{"key":"e_1_2_5_16_2","first-page":"1","volume-title":"Medical Disorders During Pregnancy","author":"Barron WM","year":"1995"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90597-3"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92202-4"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199207030-00007"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/1.2.175"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(12)80016-0"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(93)90770-W"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(87)80104-7"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70622-7"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)90762-V"},{"key":"e_1_2_5_26_2","volume-title":"American Hospital Formulary Service","author":"McEvoy GK","year":"1995"},{"key":"e_1_2_5_27_2","first-page":"90","volume-title":"A Guide to Effective Care in Pregnancy and Childbirth","author":"Collins RC","year":"1995"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(88)90090-7"},{"key":"e_1_2_5_29_2","first-page":"1289","article-title":"A centile chart for birth weight for an urban population of the Western Cape","volume":"85","author":"Theron GB","year":"1995","journal-title":"S Afr Med J"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198510020-00002"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198632060-00004"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.68.11.478"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(12)80005-6"},{"key":"e_1_2_5_34_2","first-page":"69","article-title":"Pharmacology of platelet activation\u2010inhibitory drugs","volume":"38","author":"Rao GH","year":"1994","journal-title":"Indian J Physiol Pharmacol"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91011-Z"},{"key":"e_1_2_5_36_2","first-page":"331","article-title":"Nifedipine in the treatment of severe preeclampsia","volume":"77","author":"Fenakel J","year":"1991","journal-title":"Obstet Gynecol"},{"key":"e_1_2_5_37_2","first-page":"182","volume-title":"Medical Disorders in Obstetric Practice","author":"Redman C","year":"1996"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641959409072226"},{"key":"e_1_2_5_39_2","first-page":"555","article-title":"Fetal and neonatal outcome in patients with severe pre\u2010eclampsia before 34 weeks","volume":"71","author":"Odendaal HJ","year":"1987","journal-title":"S Afr Med J"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199607253350407"},{"key":"e_1_2_5_41_2","first-page":"169","article-title":"Combined \u03b1\u2010 and \u03b2\u2010adrenoceptor antagonism with prazosin and oxprenolol in control of severe hypertension in pregnancy","volume":"94","author":"Lubbe WF","year":"1981","journal-title":"N Z Med J"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189675"},{"key":"e_1_2_5_43_2","unstructured":"NormanK GeertsL SmithM OdendaalH VanZylJ.Clinical management of the fetus with ARED umbilical artery Doppler flow: a five year prospective study [abstract].Eleventh Congress of the International Perinatal Doppler Society Innsbruck Austria July 1998."},{"key":"e_1_2_5_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1988.tb06818.x"},{"key":"e_1_2_5_45_2","first-page":"192","article-title":"The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension","volume":"79","author":"Puzey MS","year":"1991","journal-title":"S Afr Med J"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641959109012921"},{"key":"e_1_2_5_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1997.tb11978.x"},{"key":"e_1_2_5_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199703000-00023"},{"key":"e_1_2_5_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)24034-7"},{"key":"e_1_2_5_50_2","first-page":"231","article-title":"Prazosin and oxprenalol therapy in hypertension","volume":"64","author":"Dommisse J","year":"1983","journal-title":"S Afr Med J"},{"key":"e_1_2_5_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb02213.x"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2000.tb13337.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2000.tb13337.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T13:39:09Z","timestamp":1698586749000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2000.tb13337.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1111\/j.1471-0528.2000.tb13337.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2000.tb13337.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"2005-08-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}